.Following a bad showing for Lykos Rehabs' MDMA applicant for trauma at a recent FDA advising commit...
.AN2 Therapeutics is actually reassessing its business in response to lackluster midphase data, prom...
.Merck & Co. is actually paying $700 million beforehand to challenge Amgen in a blood cancer mark...
.With Gilead Sciences about to an FDA choice for its liver ailment medication seladelpar, the firm h...
.Chief executive officer David Ricks can easily see the business setting up tents at basecamp respon...
.Bed mattress Liquidators has switched Entero Therapies white as a slab. The creditor got Entero to ...
.Exelixis is actually quiting on its tissue aspect (TF)- targeting antibody-drug conjugate after wra...
.3 full weeks after Roche's Genentech system walked away from an SHP2 inhibitor treaty, Relay Rehab ...
.Stoke Therapeutics' Dravet disorder medicine has been freed from a partial hold, getting rid of the...
.Fierce Biotech Partner Publisher Gabrielle Masson offered the 2024 class of Tough 15 victors on the...